BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 12353945)

  • 1. Statin-associated myopathy with normal creatine kinase levels.
    Phillips PS; Haas RH; Bannykh S; Hathaway S; Gray NL; Kimura BJ; Vladutiu GD; England JD;
    Ann Intern Med; 2002 Oct; 137(7):581-5. PubMed ID: 12353945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summaries for patients. Muscle abnormalities in four patients taking statins to treat unfavorable cholesterol levels.
    Ann Intern Med; 2002 Oct; 137(7):I45. PubMed ID: 12353973
    [No Abstract]   [Full Text] [Related]  

  • 3. Muscle symptoms associated with statins: a series of twenty patients.
    Soininen K; Niemi M; Kilkki E; Strandberg T; Kivistö KT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):51-4. PubMed ID: 16433891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin induced myopathy does not show up in MIBI scintigraphy.
    Lupattelli G; Palumbo B; Sinzinger H
    Nucl Med Commun; 2001 May; 22(5):575-8. PubMed ID: 11388581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myopathy due to statins, a dose-dependent effect, and of what kind?].
    León Vázquez F; Llanes De Torres R; Morón Merchante I
    Aten Primaria; 2002; 30(3):188. PubMed ID: 12139858
    [No Abstract]   [Full Text] [Related]  

  • 6. [Statin-induced dysphagia].
    Edholm B
    Ugeskr Laeger; 2010 Feb; 172(7):544-5. PubMed ID: 20156405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible myopathy after statin therapy in patients with normal creatine kinase levels.
    Bennett WE; Drake AJ; Shakir KM
    Ann Intern Med; 2003 Mar; 138(5):436-7. PubMed ID: 12614104
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of statins on skeletal muscle function.
    Parker BA; Capizzi JA; Grimaldi AS; Clarkson PM; Cole SM; Keadle J; Chipkin S; Pescatello LS; Simpson K; White CM; Thompson PD
    Circulation; 2013 Jan; 127(1):96-103. PubMed ID: 23183941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy.
    Skottheim IB; Bogsrud MP; Hermann M; Retterstøl K; Åsberg A
    Mol Diagn Ther; 2011 Aug; 15(4):221-7. PubMed ID: 21815705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Creatine kinase increase under simvastatin--therapeutic consequences?].
    Rasche-Schürmann CC; Picksak G; Stichtenoth DO
    Med Monatsschr Pharm; 2008 Jan; 31(1):25-7. PubMed ID: 18522017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats.
    Abdelbaset M; Safar MM; Mahmoud SS; Negm SA; Agha AM
    Can J Physiol Pharmacol; 2014 Jun; 92(6):481-9. PubMed ID: 24896301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SLCO1B1*5 genetic variant is associated with statin-induced side effects.
    Voora D; Shah SH; Spasojevic I; Ali S; Reed CR; Salisbury BA; Ginsburg GS
    J Am Coll Cardiol; 2009 Oct; 54(17):1609-16. PubMed ID: 19833260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin-associated myopathy with normal creatine kinase levels. Case report from a Norwegian family.
    Trøseid M; Henriksen OA; Lindal S
    APMIS; 2005 Sep; 113(9):635-7. PubMed ID: 16218940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin myopathy: a lipid clinic experience on the tolerability of statin rechallenge.
    Fung EC; Crook MA
    Cardiovasc Ther; 2012 Oct; 30(5):e212-8. PubMed ID: 21884002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
    Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
    Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical and muscular pathological features of statin-induced myopathy].
    Meng L; Lu Y; Zhang W; Wang Z; Lyu H; Yuan Y
    Zhonghua Nei Ke Za Zhi; 2015 Aug; 54(8):716-20. PubMed ID: 26674629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia.
    Draeger A; Monastyrskaya K; Mohaupt M; Hoppeler H; Savolainen H; Allemann C; Babiychuk EB
    J Pathol; 2006 Sep; 210(1):94-102. PubMed ID: 16799920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
    Nissen SE; Stroes E; Dent-Acosta RE; Rosenson RS; Lehman SJ; Sattar N; Preiss D; Bruckert E; Ceška R; Lepor N; Ballantyne CM; Gouni-Berthold I; Elliott M; Brennan DM; Wasserman SM; Somaratne R; Scott R; Stein EA;
    JAMA; 2016 Apr; 315(15):1580-90. PubMed ID: 27039291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive myopathy with up-regulation of MHC-I associated with statin therapy.
    Needham M; Fabian V; Knezevic W; Panegyres P; Zilko P; Mastaglia FL
    Neuromuscul Disord; 2007 Feb; 17(2):194-200. PubMed ID: 17241784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranolazine-induced myopathy in a patient on chronic statin therapy.
    Correa D; Landau M
    J Clin Neuromuscul Dis; 2013 Mar; 14(3):114-6. PubMed ID: 23492463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.